Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is recalling 696 bottles of Pregabalin capsules (50 mg), used for the treatment of epilepsy, anxiety, and nerve pain, in the US market. The Mumbai-based company is recalling the affected lot due to failed tablet/capsule specifications: out of specification results for particle size distribution and bulk density of the active pharmaceutical ingredient. New Jersey-based Sun Pharmaceutical Industries Inc, a unit of the company, initiated Class II nationwide (US) recall of the affected lot on October 22 last year. 

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.